about
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisCurrent concept of neuromyelitis optica (NMO) and NMO spectrum disorders.Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method.Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis.Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLAClinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.Treatment of Neuromyelitis Optica: Review and Recommendations.A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis.Candidate antigens specifically detected by cerebrospinal fluid-IgG in oligoclonal IgG bands-positive multiple sclerosis patients.Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis.Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis.CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.Efficiency of antibody therapy in demyelinating diseases.Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations.Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.Influence of pregnancy on neuromyelitis optica spectrum disorder.Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica.Relapsing focal myositis: the localization detected by gallium citrate Ga 67 scintigraphy.Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution.Chloride imbalance between serum and CSF in the acute phase of neuromyelitis optica.Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica.Occurrence of acute large and edematous callosal lesions in neuromyelitis optica.CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis.Is MOG-IgG another biomarker for neuromyelitis optica?Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange.Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.A case of very long longitudinally extensive transverse myelitis (LETM) with necrotizing Vasculitis.Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications.Clinical and laboratory features of myelitis patients with anti-neutrophil cytoplasmic antibodies.A case with anti-galactocerebroside antibody-positive Mycoplasma pneumoniae meningoencephalitis presenting secondary hypersomnia.Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study.Recurrent hypogeusia in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
P50
Q29615952-94DA4ED2-0D22-4CF4-96C1-B0BDEFE78E26Q30577078-3399B3E0-2998-42C6-BCE1-CE2B815BE8ECQ31084417-1F506EEB-9C1C-45ED-9F4C-E718B5B3B7ECQ31110030-6D1CE4F3-FDA8-4224-930A-1788AE17617FQ33256695-3B424101-5E8D-4AD8-9C3F-A488B3FA1CD1Q34648673-263D8E51-D2C1-4392-8EB9-E8EFFB0B0A5CQ35101408-F2F33013-C73E-4317-BDA9-EAFBD08F81D6Q36143187-9BB9A856-CB39-42BA-8C4B-15DBAC2E0179Q36293971-F8B7DF5B-BE7C-486C-802E-A11BBB60376BQ37588037-D611B44A-F14C-467C-A062-0353521BFA37Q37777937-AC21B0DC-0DF6-4EDA-91BF-9EA19F252DCAQ38300410-B5BA0584-F282-48E5-8315-7961B72E8F78Q38306989-B88BB238-4073-4F10-851E-5F236E42FB69Q38316822-AE7A66A7-56E5-4586-88B4-F5D3590B0BE8Q39294103-257E4142-12EB-46E5-9F74-E7F48C9E4D2DQ39859856-8F69F4AD-E292-48B5-8CD2-BA7FF05BAA43Q40045794-9EC4F7D0-F380-4916-B25D-5F166F18F967Q41720432-AFBD0BF6-9D86-4B6C-AA07-3DEEE85DBB22Q45061248-51267388-9640-4C35-99E5-6473CC460C9BQ45164243-0E44B347-C3C9-4C72-80C2-05B9AF41ED06Q45774295-80AAB3B5-8285-4600-872C-FF835B8C7B65Q46622914-0A8141A7-500E-4F7E-A4E0-A7A17FA26473Q46794975-89C08418-EFDE-41EA-899A-D1099CCFDCF0Q46847894-D171FF92-C5FC-4909-8031-EA2008EA8643Q46927023-C0773510-FC8F-41D6-9E4B-2448C3285BA2Q47227545-4FBB36D5-5ED2-4745-9556-400BE4EA7FF0Q47387385-849263CF-88A4-425D-A5A0-740A71751EA8Q47820080-489B7564-FA3F-43F9-AA38-F901E19EABCAQ47953458-63244EA4-53C4-4AA8-9EFF-30B90BF891BAQ48164587-CC13F9A0-7E7A-45A4-B65B-13E5CE3F7B1CQ48219268-26826CF3-9181-4A56-8FA1-D92B370C31E3Q48241137-1F385A5E-B137-4A1D-94CA-22DF10036BA4Q48275557-84136A4E-478E-468E-BEC6-037B7EEE8BFAQ48335583-99F536D5-259A-49F5-B87E-BD2C34F0F2B7Q48347841-0F4EBE67-7C8A-4801-9CD9-8E8B6393270BQ48378242-D1F90604-8C69-408D-BEF9-DCD9B67C9217Q48463224-E7520F58-828F-456D-8312-FF966B2D1C0DQ48614752-4A8DD683-C580-4E25-847F-8E6FFCE992AEQ48617819-01ACE8B4-07A5-42AA-9FF0-4261D09E7C60Q48687629-7E3A8D01-822E-49D6-BD2F-764B2011B6E2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ichiro Nakashima
@ast
Ichiro Nakashima
@en
Ichiro Nakashima
@es
Ichiro Nakashima
@nl
Ichiro Nakashima
@sl
type
label
Ichiro Nakashima
@ast
Ichiro Nakashima
@en
Ichiro Nakashima
@es
Ichiro Nakashima
@nl
Ichiro Nakashima
@sl
prefLabel
Ichiro Nakashima
@ast
Ichiro Nakashima
@en
Ichiro Nakashima
@es
Ichiro Nakashima
@nl
Ichiro Nakashima
@sl
P106
P1153
35414701000
P31
P496
0000-0002-2612-8948